Fusion Pharmaceuticals Cash from Investing (TTM) Analysis

Fusion Pharmaceuticals Inc (FUSN)

21.52 +0.10 (+0.44%) USD | NASDAQ | May 01, 15:25

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	-42.76M
September 30, 2023	-80.45M
June 30, 2023	-56.53M
March 31, 2023	-20.57M
December 31, 2022	23.09M
September 30, 2022	96.92M
June 30, 2022	91.88M
March 31, 2022	85.90M
December 31, 2021	37.77M

Date	Value
September 30, 2021	-148.23M
June 30, 2021	-235.41M
March 31, 2021	-239.24M
December 31, 2020	-210.45M
September 30, 2020	-55.46M
June 30, 2020	-0.687M
March 31, 2020	-0.631M
December 31, 2019	-0.456M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-239.24M

Minimum

Mar 2021

96.92M

Maximum

Sep 2022

-44.43M

Average

-20.57M

Median

Mar 2023

Cash from Investing (TTM) Benchmarks